Aether Industries Limited (AETHER) Earnings Call Transcripts
Aether Industries Limited's Latest Earnings Call - Q4 FY2026
Aether Industries Limited reported its Q4 and FY '26 results, showing significant growth with a 38% YoY increase in revenue to INR 11,601 million and a 53% increase in EBITDA to INR 3,547 million. The EBITDA margin improved to 31% from 28% in FY '25. Despite a decline in Q4 revenue to INR 3,051 million from INR 3,188 million in Q3 due to one-off items, the company maintains a positive outlook. Management highlighted strong pricing in its large-scale manufacturing business, with a 20% YoY increase, and anticipates sustained demand and pricing. Guidance was not explicitly provided, but management indicated expectations of stable margins and significant contributions from new sites and products in FY '27.
Reported metrics
| Metric | Value |
|---|---|
| Revenue | INR 11,601 million (beat) |
| EBITDA | INR 3,547 million (beat) |
| EBITDA Margin | 31% (beat) |
| PAT | INR 2,195 million (beat) |
| Q4 Revenue | INR 3,051 million (miss) |
Guidance from management
Management expects stable margins with EBITDA between 29% to 30% and PAT around 19% to 20% for FY '27. No specific revenue guidance was provided, but significant contributions from Site 5 and new products are anticipated.
What management said
Yes. But we do have a natural hedge where we are importing certain products also from various parts of the world. So we have a natural hedge on this. We try to capitalize this as much as possible. However, our exports currently because of various uncertainties had been reduced by the CN customers, which had structurally put their Indian subsidiaries ahead. So we are selling to Indian subsidiaries and then they are ex...
For the CM at least, which is an open cost P&L. So for that, it will not be -- it will not impact. But for LSM, there will be some delta wherein certain margins will go up and then it will subside.
What analysts pressed on
Analysts questioned the impact of currency fluctuations on exports and the potential benefits. Concerns were also raised about the sustainability of pricing and demand given geopolitical disruptions. Management assured that pricing remains strong and demand steady.
Main topics on the call
- Pricing and Demand Resilience — Management reported a 20% YoY and 18% QoQ increase in product prices in Q4 due to market disruptions, with prices maintained into April and May. They believe this pricing environment is sustainable in the medium term.
- Expansion and New Product Launches — Three new large-scale manufacturing products are set to launch by early June, with validation batches completed and orders in hand. Site 5 is expected to significantly contribute to revenue growth.
- R&D and Infrastructure Expansion — Aether completed an interim R&D expansion with new labs and equipment, expecting commercialization in Q2 FY '27. A new R&D facility is scheduled for FY '28, doubling current capacity.
- Financial Performance — FY '26 revenue increased by 38% YoY to INR 11,601 million, with EBITDA up 53% YoY. Q4 revenue declined due to one-off items, but management expects improvement as new projects commence.
Read the full Aether Industries Limited transcript (Q4 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About Aether Industries Limited
Aether Industries Limited (AETHER) is a publicly listed company in the Pharmaceuticals industry, within the Health Care sector. It trades on NSEI and is based in IN. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 16 calls on record spanning June 17, 2022 to July 31, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 16 Aether Industries Limited earnings call transcripts on record, spanning June 17, 2022 to July 31, 2026. Based on this history, Aether Industries Limited reports quarterly. The most recent call on file is dated July 31, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- AETHER
- Exchange
- NSEI
- Country
- IN
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Calls on record
- 16
- First call
- June 17, 2022
- Most recent
- July 31, 2026
- Reporting cadence
- quarterly
| Quarter | Date | |
|---|---|---|
| Q1 FY2027 | Jul 31, 2026 | Read transcript → |
| Q4 FY2026 | May 15, 2026 | Read transcript → |
| Q1 FY2026 | Jul 24, 2025 | Read transcript → |
| Q4 FY2025 | May 3, 2025 | Read transcript → |
| Q3 FY2025 | Jan 17, 2025 | Read transcript → |
| Q2 FY2025 | Oct 18, 2024 | Read transcript → |
| Q1 FY2025 | Jul 19, 2024 | Read transcript → |
| Q4 FY2024 | May 21, 2024 | Read transcript → |
| Q3 FY2024 | Feb 1, 2024 | Read transcript → |
| Q2 FY2024 | Oct 31, 2023 | Read transcript → |
| Q1 FY2024 | Jul 26, 2023 | Read transcript → |
| Q4 FY2023 | May 8, 2023 | Read transcript → |
| Q3 FY2023 | Jan 20, 2023 | Read transcript → |
| Q2 FY2023 | Nov 14, 2022 | Read transcript → |
| Q1 FY2023 | Jul 26, 2022 | Read transcript → |
| Q4 FY2022 | Jun 17, 2022 | Read transcript → |